EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieVergleichsstudieOpen Access · CC BY-NC-ND 4.0

Quadruple therapies show a higher eradication rate compared to standard triple therapy for Helicobacter pylori infection within the LEGACy consortium. A multicenter observational study in European and Latin American countries

Patricio Medel-Jara iD, Diego Reyes Placencia iD, Eduardo Fuentes-López, Oscar Corsi, Gonzalo Latorre, Rosario Antón, Elena Jiménez, Ana Miralles-Marco, Carmelo Caballero, Hugo Boggino, Daniel Cantero, Rita Barros und 20 weitere

United European Gastroenterology Journal · 2024

DOI: 10.1002/ueg2.12605 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift United European Gastroenterology Journal, 2024. Verfasst von Patricio Medel-Jara und 31 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Medicina, Programa de Doctorado en Epidemiología, Pontificia Universidad Católica de Chile, Santiago, Chile. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori, Drug Therapy, Combination, Anti-Bacterial Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: FONDECYT Role of the genomic and microbiome profile in gastric carcinogenesis: prospective endoscopic follow-up, Fondo de Financiamiento de Centros de Investigación en Áreas Prioritarias, CONACyT Unión Europea-CELAC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Gastric cancer (GC) is one of the most lethal malignancies worldwide. Helicobacter pylori is the primary cause of GC; therefore, its eradication reduces the risk of developing this neoplasia. There is extensive evidence regarding quadruple therapy with relevance to the European population. However, in Latin America, data are scarce. Furthermore, there is limited information about the eradication rates achieved by antibiotic schemes in European and Latin American populations.

Objective

To compare the effectiveness of standard triple therapy (STT), quadruple concomitant therapy (QCT), and bismuth quadruple therapy (QBT) in six centers in Europe and Latin America.

Methods

A retrospective study was carried out based on the LEGACy registry from 2017 to 2022. Data from adult patients recruited in Portugal, Spain, Chile, Mexico, and Paraguay with confirmed H . pylori infection who received eradication therapy and confirmatory tests at least 1 month apart were included. Treatment success by each scheme was compared using a mixed multilevel Poisson regression, adjusting for patient sex and age, together with country‐specific variables, including prevalence of H . pylori antibiotic resistance (clarithromycin, metronidazole, and amoxicillin), and CYP2C19 polymorphisms.

Results

772 patients were incorporated (64.64% females; mean age of 52.93 years). The total H . pylori eradication rates were 75.20% (255/339) with STT, 88.70% (159/178) with QCT, and 91.30% (191/209) with QBT. Both quadruple therapies (QCT‐QBT) showed significantly higher eradication rates compared with STT, with an adjusted incidence risk ratio (IRR) of 1.25 ( p :

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsHelicobacter pyloriDrug Therapy, CombinationAnti-Bacterial AgentsProton Pump InhibitorsHumansMaleFemaleMiddle AgedLatin AmericaRetrospective StudiesEuropeAdultTreatment OutcomeMetronidazoleAgedAmoxicillinCytochrome P-450 CYP2C19Drug Resistance, BacterialBismuthStomach NeoplasmsClarithromycin

Stichwörter der Autor:innen

Helicobacter pyloricombination drug therapiesgastric cancerquadruple therapystandard triple therapy

Substanzen

Anti-Bacterial AgentsProton Pump InhibitorsMetronidazoleAmoxicillinCytochrome P-450 CYP2C19BismuthCYP2C19 protein, humanClarithromycin

Autor:innen und Institutionen

  • Facultad de Medicina, Programa de Doctorado en Epidemiología, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Facultad de Medicina, Programa de Farmacología y Toxicología, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Facultad de Medicina, Carrera de Terapia Ocupacional, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Facultad de Medicina, Departamento de Ciencias de la Salud, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Digestive Medicine Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.

ORCID-Profile: Patricio Medel-Jara, Diego Reyes Placencia, João Santos-Antunes, Olga P Nyssen, Alberto M Leon-Takahashi, Erika Ruiz-Garcia, Tania Fleitas, Arnoldo Riquelme

Förderung

  • FONDECYT Role of the genomic and microbiome profile in gastric carcinogenesis: prospective endoscopic follow-up
  • Fondo de Financiamiento de Centros de Investigación en Áreas Prioritarias
  • CONACyT Unión Europea-CELAC
  • Program ICN-ANID
  • HORIZON EUROPE Innovative Europe
  • FONIS
  • CECAN: Centro para la prevención y el control del cáncer
  • Fondo Nacional de Desarrollo científico y Tecnológico

Zitieren

APA

Medel-Jara, P., Reyes Placencia, D., Fuentes-López, E., Corsi, O., Latorre, G., Antón, R., Jiménez, E., Miralles-Marco, A., Caballero, C., Boggino, H., Cantero, D., Barros, R., Santos-Antunes, J., Díez, M., Quiñones, L. A., Riquelme, E., Rollán, A., Cerpa, L. C., Valdés, I., …, & Riquelme, A. (2024). Quadruple therapies show a higher eradication rate compared to standard triple therapy for Helicobacter pylori infection within the LEGACy consortium. A multicenter observational study in European and Latin American countries. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.12605

Vancouver

Medel-Jara P, Reyes Placencia D, Fuentes-López E, Corsi O, Latorre G, Antón R, et al. Quadruple therapies show a higher eradication rate compared to standard triple therapy for Helicobacter pylori infection within the LEGACy consortium. A multicenter observational study in European and Latin American countries. United European Gastroenterology Journal. 2024. doi:10.1002/ueg2.12605

BibTeX
@article{MedelJara2024,
  author = {Medel-Jara, Patricio and Reyes Placencia, Diego and Fuentes-López, Eduardo and Corsi, Oscar and Latorre, Gonzalo and Antón, Rosario and Jiménez, Elena and Miralles-Marco, Ana and Caballero, Carmelo and Boggino, Hugo and Cantero, Daniel and Barros, Rita and Santos-Antunes, João and Díez, Marc and Quiñones, Luis A and Riquelme, Erick and Rollán, Antonio and Cerpa, Leslie C and Valdés, Ivania and Nyssen, Olga P and Moreira, Leticia and Gisbert, Javier P and Camargo, M Constanza and Ortiz-Olvera, Nayeli and Leon-Takahashi, Alberto M and Ruiz-Garcia, Erika and Fernández-Figueroa, Edith A and Garrido, Marcelo and Owen, Gareth I and Cervantes, Andrés and Fleitas, Tania and Riquelme, Arnoldo},
  title = {Quadruple therapies show a higher eradication rate compared to standard triple therapy for Helicobacter pylori infection within the LEGACy consortium. A multicenter observational study in European and Latin American countries},
  journal = {United European Gastroenterology Journal},
  year = {2024},
  doi = {10.1002/ueg2.12605}
}
Kostenlos starten →